Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Astrana Health (ASTH)

Astrana Health Q1 revenue rises 56% to $965.1 million; net income up 116%

Positive Impact 3 of 5 earnings Written later

Astrana Health reported first-quarter 2026 revenue of $965.1 million, up 56% from a year earlier, and net income attributable to the company of $14.4 million, up 116%. The company reiterated its full-year 2026 revenue and Adjusted EBITDA guidance and gave a second-quarter outlook, so shareholders see both higher reported profit and a steady forecast.

Key points

  • Total revenue of $965.1 million, up 56% from $620.4 million; diluted EPS of $0.29 versus $0.14
  • Net income attributable to Astrana of $14.4 million, up 116% from $6.7 million; Adjusted EBITDA of $66.3 million, up 82%
  • Q2 2026 guidance: total revenue of $965 million to $1,000 million and Adjusted EBITDA of $65 million to $70 million
  • Full-year 2026 guidance reiterated: total revenue of $3.8 billion to $4.1 billion and Adjusted EBITDA of $250 million to $280 million

The filing

CompanyAstrana Health (ASTH)
Form8-K, current report
Filed with the SECMay 7, 2026, 4:12 PM ET
Accession number0001104659-26-057134

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:54 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.